+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Aboriginal Cancer Survivors and Carers Advocacy Groups Grant

Cancer Institute NSW

Applications are now open for the Aboriginal Cancer Survivors and Carers Advocacy Groups GrantAbout the Grant Program

This grant supports Aboriginal Medical Services (AMS), Aboriginal Community Controlled Health Organisations (ACCHOs), and Aboriginal Community Controlled Organisations (ACCOs) to establish or strengthen culturally safe, community-led support groups for Aboriginal people affected by cancer, as well as their families and carers.

Grants of up to $20,000 are available, with funding awarded on a non-competitive, first-in, first-served basis to applicants who meet the eligibility and essential criteria outlined in the grant guidelines

Objectives

Create welcoming, and trauma-informed environments that support Aboriginal people affected by cancer to feel respected, connected, and empowered, fostering trust, participation, shared learning, and healing through culturally grounded group support.
Improve equitable access to cancer services by reducing barriers and strengthening culturally safe, responsive and high-quality care for Aboriginal people, their families and carers across the cancer continuum.
Strengthen participants confidence to engage with cancer care providers and make informed decisions about their treatment and wellbeing, enhancing health outcomes and trust between communities and healthcare providers within the cancer eco-system.

Application Process

Submit applications to CINSW-Grants@health.nsw.gov.au along with the following:
- Completed application form
- Organisation endorsement letter (must be submitted using the Cancer Institute’s template)

Applications open 12:00pm (midday) on Monday 13th April 2026

Applications close 12:00pm (midday) on Monday 4th May 2026 (or when funding allocation is exhausted)

Reporting requirements

Successful applicants will be required to submit progress and final reports, including financial reporting, according to the Cancer Institute NSW Grants Agreement.

Information Sessions

The Cancer Institute NSW will be holding an information session for this grant:

Wednesday 15th April 1–to2pm.

To register, please email CINSW-Grants@health.nsw.gov.au. Questions and answers from this session will be compiled into a Frequently Asked Questions document that will available on this page after the session.

AI Based Application Success Predictor

🌏 1. Alignment with NSW Cancer Plan (Top Predictor)

All funded projects must align with:
- NSW Cancer Plan priorities
- Goals to reduce cancer burden in New South Wales

👉 Misalignment with state priorities is a major rejection reason

🎯 2. Clear Impact on Patients or Population

Successful proposals clearly demonstrate:

Improvements in:
- Cancer outcomes
- Early detection
- Treatment or care delivery
Real-world applicability in NSW

👉 Emphasis is on health system and population impact, not just publications

🔄 3. Strong Translational Focus (Critical Predictor)

Movement from:
- Research → clinical practice → policy
Projects that:
- Improve implementation of care
- Translate evidence into practice

👉 Translational and implementation research are highly prioritized

🤝 4. Collaboration & Health System Integration

High success rates are seen in:

Partnerships between:
- Universities
- Hospitals
- Local Health Districts
Integration with real clinical workflows

👉 Collaboration is essential for statewide impact

🧑‍🤝‍🧑 5. Focus on Priority & Underserved Populations

CINSW strongly values projects targeting:

Aboriginal communities
Rural and remote populations
Multicultural groups

👉 Equity-focused proposals have higher success probability

🧪 6. Feasible & Well-Structured Study Design

Realistic implementation plan
Clear milestones and deliverables
Risk management strategy

👉 Lack of feasibility or risk planning is a common rejection factor

👩‍🔬 7. Investigator Track Record & Delivery Capacity

Evidence of:
- Publications
- Previous relevant work
Demonstrated ability to deliver outcomes

👉 “Can this team actually execute?” is a key reviewer question

🏥 8. Strong Institutional Support

Backing from:
- NSW-based institutions (mandatory for most schemes)
Access to:
- Infrastructure
- Data
- Clinical settings

👉 NSW affiliation is a strict eligibility requirement

📊 9. Community & Consumer Involvement

Inclusion of:
- Patient perspectives
- Community engagement

👉 Increasingly important in evaluation

💰 10. Realistic Budget & Sustainability

Budget aligned with project scope
Long-term sustainability beyond funding

👉 Efficient use of public funds is emphasized

📊 Summary: Key Predictors (Ranked)

Highest impact factors:

Alignment with NSW Cancer Plan
Real-world patient/population impact
Translational/implementation focus

Moderate predictors:
4. Collaboration with health system
5. Focus on underserved populations
6. Feasibility & study design

Supporting factors:
7. Investigator track record
8. Institutional support (NSW-based)
9. Budget & sustainability

💡 Insider Insight

Compared to other cancer funders:

Cancer Institute NSW is:
👉 health-system driven (policy + implementation focus)
Not purely academic or pharma-oriented

👉 Key success question:
“Will this improve cancer outcomes across NSW in a practical, scalable way?”

Specialties

Cancer

Eligibility Requirements

Eligible applicants include NSW-based:

• Aboriginal Medical Services (AMS),

• Aboriginal Community Controlled Health Organisations (ACCHO),

• Aboriginal Community Controlled Organisations (ACCO).

Out of Scope

The following are not eligible for funding:

• Projects delivered outside of NSW

• Capital purchases exceeding $2,000 (eg. machinery, equipment, vehicles)

• Salaries for ongoing positions (backfilling permitted)

• Cash-based participation incentives (eg. direct cash payments to participants)

• Administration, overhead and contingency fees

Essential criteria

Applications must demonstrate:

Aboriginal Leadership

• The project is led by an eligible AMS, ACCHO, ACCO.

• Aboriginal governance and decision-making are embedded throughout the project.

Meaningful Community Consultation

• Evidence of community co-design and consultation.

• Community priorities will inform the project approach.

• Use of culturally appropriate engagement methods (e.g. yarning circles, workshops).

Cancer Focus and Alignment

• Plans to address a community identified cancer priority across the cancer continuum.

• Alignment with priorities and principles in the NSW Aboriginal Cancer Strategy.

• A detailed and realistic budget that aligns with the proposed activities.

Sponsor Details

Sponsor Institute/Organizations: Cancer Institute NSW

Sponsor Type: Corporate/Non-Profit

Address: Locked Bag 2030, St Leonards NSW 1590 Level 4, 1 Reserve Road St Leonards NSW 2065 ABN: 48 538 442 594

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity